The Office of the US Trade Representative Office announced on Wednesday (November 23) that the United States will extend tariffs on exemptions to China and crown -related imported medical products.

According to the press release issued by the Office of the US Economic and Trade Representative on the 23rd, the exemption of these products was originally scheduled to expire on November 30, and now it will be extended for another 90 days.Continue to cope with the crown disease.

The Office of the US Economic and Trade Representative was announced as early as December 2020 that 80 types of medical products related to crown diseases imported by China were exempted from China, and then 19 products were added.The exemption period for these 99 products was extended to September 30 last year, and then extended to November 30 of the same year.The exemption period of 81 products was extended to the tariff period to May 31st this year, and then extended to the 30th of this month.

According to AFP on Thursday (24th), these products include disinfected hand-sterilization pump bottle, disinfection paper towel plastic box, sphygmomanometer, finger pulse blood oxygenometer, nuclear magnetic resonance machine and X-light platformwait.

The Office of the US Trade Representative said that they may consider extending or adjusting the exemption and exemption of tariffs in accordance with the "appropriate" situation.

In response to the highest level in the past decades, President Biden was under pressure to cancel the 301 tariff measures to China.

These tariffs were formulated during the administration of former US President Trump, which caused the Sino -US trade relations to heat up sharply.At that time, the US government imposed tariffs of US $ 350 billion (RMB 480.7 billion) on the United States' transmission and US products on the grounds of unfair economic and trade operations and the stolen US science and technology and intellectual property rights.

Washington and Beijing signed the first phase of the Sino -US economic and trade agreement in January 2020. At that time, China stated that it would purchase at least US $ 200 billion in US products and services in 2020 and 2021, but it was later received.The impact of the crown disease has failed to meet the standard.